nalidixic acid has been researched along with Dermatitis, Atopic in 1 studies
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, SC | 1 |
| Huang, TH | 1 |
| Chiu, CH | 1 |
| Chou, WL | 1 |
| Alalaiwe, A | 1 |
| Yeh, YC | 1 |
| Su, KW | 1 |
| Fang, JY | 1 |
1 other study available for nalidixic acid and Dermatitis, Atopic
| Article | Year |
|---|---|
The atopic dermatitis-like lesion and the associated MRSA infection and barrier dysfunction can be alleviated by 2,4-dimethoxy-6-methylbenzene-1,3-diol from Antrodia camphorata.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Antrodia; Cell Line; Chemokines; Dermatit | 2018 |